z-logo
open-access-imgOpen Access
Longterm follow‐up of patients with multifocal choroiditis and panuveitis
Author(s) -
Vianna Raul N. G.,
Özdal Pinar Ç.,
Filho João Pessoa Souza,
Ventura Marcelo Palis,
Saraiva Vinicius S.,
Deschênes Jean
Publication year - 2004
Publication title -
acta ophthalmologica scandinavica
Language(s) - English
Resource type - Journals
eISSN - 1600-0420
pISSN - 1395-3907
DOI - 10.1111/j.1600-0420.2004.00343.x
Subject(s) - medicine , visual acuity , choroiditis , ophthalmology , uveitis , choroidal neovascularization , complication , surgery , retrospective cohort study
. Purpose:  To report the visual prognosis and longterm complications in patients with multifocal choroiditis and panuveitis (MCP).Methods:  A retrospective study was performed with patients who met inclusion criteria for MCP at the Uveitis Clinic, Royal Victoria Hospital, McGill University, Montreal, Canada. Information collected included duration of follow‐up, visual acuity (VA) measured at each clinical visit, ocular and systemic treatment and ocular complications observed during follow‐up.Results:  Nineteen patients (37 eyes) with MCP with a mean follow‐up of 76.9 months were studied. Kaplan−Meier survival analysis showed a decrease in the proportion of patients with a final VA ≥ 20/40 over time. Cystoid macular oedema was seen in 29.7% of the eyes and was the most frequent macular abnormality observed in our group. On the other hand, choroidal neovascularization was detected in only six (16.2%) of the eyes, but was related to VA < 20/200 in four of these eyes. Glaucoma was detected in 10.8% of the eyes. Cataract (posterior subcapsular and/or nuclear) was the most common longterm complication, occurring in 40% of affected eyes. Cataract surgery improved the VA in 83.3% of these eyes.Conclusion:  The visual acuity of patients with MCP decreases with time. Visual loss can occur from complications following the inflammation itself and/or iatrogenic induced by the chronic use of corticosteroids.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here